NuGen Technologies Inc.

https://www.nugen.com

NuGEN provides innovative genomic sample preparation for next-generation sequencing (NGS) and microarrays for a broad range of sample types including RNA and DNA from whole tissues, preserved and prepared tissue samples (FFPE, Formalin-Fixed Paraffin-Embedded), single cells and liquid biopsies such as from blood samples. An example of NuGEN's innovation capabilities is the newly launched Celero(TM) DNA-Seq with NuQuant library system which provides researchers with a simplified library preparation workflow with integrated quantification for DNA sequencing. Next-generation sequencing technologies are currently transforming the life sciences, e.g. the field of cancer research, due to the wealth of genetic information obtained. NGS workflows are composed of multiple complex steps, several of which need to be performed prior to loading samples in the actual sequencer. The most critical step prior to sequencing is the so called library preparation, in which many samples are processed in parallel and its correct performance is key to match the individual DNA sequences with the respective samples again after sequencing. The quality of prepared libraries has a significant impact on the sequencing process, the reproducibility and usability of the data and thereby ultimately on the overall data quality. With large numbers of samples being processed, library preparation can actually cost more than the sequencing itself. The market for library preparation has been expanding with a rate of above 10% and with an estimated size of more than one billion US dollars, it represents a significant share of the overall about 6 billion US dollars sequencing market. Costs associated with NGS overall are dropping, making the technology more affordable and widely accessible. A higher adoption of NGS and fast growing sample numbers increase the need for automation, a particular strength of Tecan, especially in the genomics area. With automation, labs can increase the throughput and eliminate unnecessary manual steps and sources of error. NuGEN's products are automation friendly and offer rapid and simple workflows designed to reduce time and cost per sample. Together with NuGEN, Tecan can leverage its automation expertise and leading position within the market for genomic instruments to offer complete solutions for NGS library preparation, comprising dedicated workstations, accompanying consumables and differentiated NGS reagents. With the Company's global presence, Tecan sees an opportunity to expand the business with an increased presence in North America, Europe as well as expanding sales capabilities in China. Established in 2000, NuGEN is well-embedded in the biotech center of the Silicon Valley, California (USA), and has over 70 employees. *

	Start	2000-01-01 established
	End	2018-09-01 renamed
	Group	Tecan (Group)
	Today	Tecan Genomics Inc. (formerly NuGen Technologies)
	Successor	Tecan Genomics Inc. (formerly NuGen Technologies)
	Industry	nucleic acid amplification (technology)
	Industry 2	amplification technology
	Person	Sood, Nitin (Qiagen 202401 SVP Head Life Science Business Area formerly NuGen + PerkinElmer + Boreal Genomics + Agilent)

	Street	201 Industrial Road Suite 310
	City	94070 San Carlos, CA
	Tel	+1-650-590-3600
		Address record changed: 2020-12-02

Basic data	Employees	C: 51 to 100 (2018-08-16)

		* Document for »About Section«: Tecan Group Ltd.. (8/16/18). "Press Release: Tecan Accelerates Broad Genomics Strategy with the Acquisition of NuGen Technologies". Männedorf.

		Record changed: 2019-03-12